Method | Model cell line | Parameters | Outcomes | Reference |
---|---|---|---|---|
Wound scratch assay | Human umbilical vein endothelial cells | The migration rate is measured as the difference of the width in between cell monolayer parts at predetermined time points | Enhanced cell migration and faster wound closure | [60] |
Human skin fibroblasts | [54] | |||
Fibroblasts or human umbilical vein endothelial cells | [69] | |||
Human dermal fibroblast | [58] | |||
Immortalized human HaCaT keratinocytes | [70] | |||
[52] | ||||
Cell proliferation assay | Human mesenchymal stromal cells | Cell Counting Kit-8 assay | Good biocompatibility, low cytotoxicity, clearly supported cell survival and proliferation | [64] |
Human umbilical vein endothelial cells | [63] | |||
RAW 264.7 murine-derived macrophages | [57] | |||
Human fibroblasts and human umbilical vein endothelial cells | [69] | |||
L929 murine fibroblasts | [68] | |||
Collagen deposition assay | Human skin fibroblasts | Quantitative analysis of immunofluorescence staining collagen type I | Promoted collagen synthesis | [54] |
Human dermal fibroblasts | [58] | |||
Tube formation assay | Human umbilical vein endothelial cells | Quantitative microscopic analysis of loop number | Promoted tube formation | [60] |
[63] | ||||
Cell migration assay | Human epidermal CB-HK-001 keratinocytes | Transwell membrane assay (8 mm pore size) | Induced cell migration | [54] |
Human umbilical vein endothelial cells | [63] | |||
Phenotype change analysis | Murine bone marrow macrophages | Quantitative real-time PCR of total RNA (GAPDH, CD206, CCR7 genes) | Upregulated expression of the M2 macrophage marker CD206, reduced expression of the M1 macrophage marker CCR7 | [63] |
RAW 264.7 murine-derived macrophages | Expression of macrophage markers, including induced nitric oxide synthase (iNOS, M1), and arginase (ARG, M2) by flow cytometry | Stimulation of M2-polarization of macrophages | [57] | |
Fibroblast differentiation assay | Human fibroblasts | α-SMA mRNA expression | Downregulation of α-SMA expression; inhibition of proliferation fibroblasts into myofibroblasts leading to scarless healing | [69] |
Inflammation gene expression | RAW 264.7 murine-derived macrophages | Quantitative real-time PCR of total RNA | Supression of pro-inflammation gene IL-23 expression and upregulation of anti-inflammation gene IL-10 | [57] |
Immune response | Human peripheral blood mononuclear cells | Cell proliferative response due to incorporation of tritiated thymidine (3 H-TdR) and its DNA binding is analyzed | No significant difference in PBMC proliferation (no immune response) | [61] |
Cell viability | Human dermal fibroblasts | MTT assay | No cytotoxic effect, increased cell proliferation | [55] |
Assessment of cytoprotectivity against H2O2 toxicity | Human mesenchymal stromal cells | MTT assay, additional treatments of the cells with 250 µM H2O2 solution for 24 h to induce cell death | Significant reduction in cell death caused by H2O2 | [65] |